{"disease":{"id":"dystrophy-retinal","name":"dystrophy retinal"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04620876","title":"Bimodal and Coaxial High Resolution Ophtalmic Imaging","phase":"NA","overall_status":"UNKNOWN","enrollment_count":1200,"lead_sponsor_name":"Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts","has_results":false},{"nct_id":"NCT04128150","title":"High Resolution Retina Imaging","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts","has_results":false},{"nct_id":"NCT04131400","title":"Establishment of the National Registry for Inherited Retinal Dystrophy in Iran","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Shahid Beheshti University of Medical Sciences","has_results":false},{"nct_id":"NCT05130385","title":"High Resolution Optical Coherence Tomography","phase":"","overall_status":"UNKNOWN","enrollment_count":550,"lead_sponsor_name":"Insel Gruppe AG, University Hospital Bern","has_results":false},{"nct_id":"NCT03613948","title":"Study on the Effects of Mutations Under Inherited Retinal Disease in Korean","phase":"","overall_status":"COMPLETED","enrollment_count":280,"lead_sponsor_name":"Gangnam Severance Hospital","has_results":false},{"nct_id":"NCT06375239","title":"Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retinal Degeneration","phase":"","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Ray Therapeutics, Inc.","has_results":false},{"nct_id":"NCT04545736","title":"Oral Metformin for Treatment of ABCA4 Retinopathy","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":56,"lead_sponsor_name":"National Eye Institute (NEI)","has_results":false},{"nct_id":"NCT05573984","title":"Natural History of PRPF31 Mutation-Associated Retinal Dystrophy","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":50,"lead_sponsor_name":"PYC Therapeutics","has_results":false},{"nct_id":"NCT06699108","title":"Study to Evaluate the Efficacy and Safety of VGR-R01 Gene Therapy in Patients With Bietti Crystalline Dystrophy","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":45,"lead_sponsor_name":"Shanghai Vitalgen BioPharma Co., Ltd.","has_results":false},{"nct_id":"NCT04690062","title":"BEOVU in the Treatment of Dystrophy-related Macular Neovascular Degeneration","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Benha University","has_results":false},{"nct_id":"NCT05902962","title":"SAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":17,"lead_sponsor_name":"PYC Therapeutics","has_results":false},{"nct_id":"NCT02723448","title":"Aclarubicin for the Treatment of Retinal Vasculopathy With Cerebral Leukodystrophy","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":4,"lead_sponsor_name":"Washington University School of Medicine","has_results":false}],"total":12},"guidelines":[],"source":"Drug Landscape verified database"}